The global Hip Prosthesis Stem market is currently witnessing a transformative phase, driven by an aging global population and a significant increase in the prevalence of osteoarthritis and hip fractures. As a premier hip prosthesis stem exporter, we recognize that the demand is no longer just about basic replacement; it's about longevity, bio-compatibility, and anatomical precision.
Technological advancements in cemented and cementless stem designs have revolutionized surgical outcomes. Today, the industry is moving toward personalized medicine. Large-scale orthopedic hubs in Europe, North America, and Asia are increasingly sourcing components that offer modular flexibility to accommodate diverse patient morphologies. The rise of medical tourism in developing regions has further spiked the demand for high-quality yet cost-effective implants, positioning Chinese medical manufacturers as vital pillars in the global supply chain.
Years of R&D
Product Series
Global Regions
ISO Compliant
The shift from traditional stainless steel to Titanium alloys and Cobalt-Chromium with hydroxyapatite (HA) coatings ensures superior osseointegration and reduces the risk of aseptic loosening.
Modern hip stems are now designed to be compatible with robotic-assisted surgery systems, allowing for sub-millimeter placement accuracy and optimized joint tensioning.
Custom-made, 3D-printed hip stems are becoming the gold standard for complex revision surgeries, providing a perfect fit for patients with bone defects.
International hospital groups and orthopedic distributors have evolved their procurement criteria. Beyond the basic regulatory approvals (like CE and ISO 13485), there is a growing emphasis on Supply Chain Resilience and Total Cost of Ownership (TCO).
What Global Buyers Look For:
Guangzhou Clerivida Medical Co., Ltd. is a leading manufacturer specializing in orthopedic implants and surgical instruments, offering a comprehensive model of research and development, production, sales, and export. The company has established a perfect quality management system and advanced production capabilities, ensuring every product meets international standards.
With over 18 years of dedicated research and development, Clerivida has developed 11 main product series, including spinal systems, intramedullary nail systems, trauma plates and screws, locking plates and screws, CMF maxillofacial systems, external fixation devices, joint replacement systems, medical power tools, general surgical instrument sets, sterilization boxes & baskets, and veterinary orthopedic solutions. Each series is designed with precision, safety, and innovation in mind, catering to diverse medical applications globally.
Guided by the principle of "quality first, service first, R&D first, innovation first," the company has earned an excellent reputation both domestically and internationally. Customer satisfaction remains the cornerstone of Clerivida’s service philosophy, emphasizing sincere service, continuous improvement, attention to detail, and integrity.
With a professional after-sales team and a pioneering spirit, Clerivida continues to provide reliable, high-quality orthopedic solutions while building long-term partnerships with clients worldwide. The company remains committed to innovation, excellence, and advancing the orthopedic medical industry.
China has emerged as a global powerhouse in medical device manufacturing, combining high-tech infrastructure with unparalleled efficiency.
By leveraging an integrated supply chain, we offer world-class implants at a fraction of the cost of Western brands, enabling hospitals to expand patient access to joint replacement.
Our R&D center in Guangzhou can rapidly iterate designs, offering customized OEM/ODM services for global brands looking for a reliable manufacturing partner.
Every hip prosthesis stem undergoes rigorous fatigue testing, surface analysis, and sterility validation, matching the highest benchmarks of the orthopedic industry.
Our products are versatile. While our primary focus is on Primary and Revision Total Hip Arthroplasty (THA) for human patients suffering from degenerative joint diseases, we have also expanded into the Veterinary Orthopedic market. High-performance mini-hip systems are now used globally to treat hip dysplasia in large canine breeds, proving the adaptability of our engineering expertise.
Whether it is a high-volume public hospital in Southeast Asia or a specialized private clinic in Europe, our Hip Joint Hemiarthroplasty Systems and Bipolar Prosthesis solutions provide the reliability surgeons need for successful patient mobilization.
As a seasoned hip prosthesis stem exporter, Guangzhou Clerivida Medical Co., Ltd. embodies the principles of Experience, Expertise, Authoritativeness, and Trustworthiness (E-E-A-T). Our decade-plus presence in the orthopedic field is backed by clinical feedback from hundreds of surgeons worldwide.
Our commitment to quality-first and R&D-driven innovation means we don't just sell products; we provide life-changing medical solutions. With professional after-sales support and an unwavering focus on surgical precision, we continue to bridge the gap between advanced medical technology and global patient care. Partner with us for reliable, high-standard orthopedic implants that set the benchmark for the industry.
Clerivida Medical
